Dr. Cooper is Chief Medical Officer, Head of Portfolio Management Committee, and Partner at HealthCare Royalty Partners (HCR). He also serves as the lead outside director of Zynerba Pharmaceuticals. With a background in cardiology and cardiac surgery, he spent 12 years with Merck in various positions, ultimately becoming the head of worldwide clinical research operations for Merck Research Laboratories. At AstraZeneca PLC, he led the company’s cardiovascular business division, responsible for everything from in-licensing and development, to commercialization. He was the founding CEO of Prism Pharmaceuticals, a specialty pharmaceutical company that he led from inception to the sale of the company to Baxter International.